The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Ceftolozane/Tazobactam: A Novel Cephalosporin/β-Lactamase Inhibitor Combination with Activity Against Multidrug-Resistant Gram-Negative Bacilli
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Infectious Diseases Society of America
Enders, J. F. (1969) · Journal of Infectious Diseases · doi:10.1093/infdis/119.3.317 · Cited by 3,286
Three Decades of β-Lactamase Inhibitors
Drawz, S. M., & Bonomo, R. A. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00037-09 · Cited by 1,709
The penicillin-binding proteins: structure and role in peptidoglycan biosynthesis
Sauvage, E., Kerff, F., Terrak, M., Ayala, J. A., & Charlier, P. (2008) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2008.00105.x · Cited by 1,317
Pseudomonas aeruginosa: all roads lead to resistance
Breidenstein, E. B. M., de la Fuente-Núñez, C., & Hancock, R. E. W. (2011) · Trends in Microbiology · doi:10.1016/j.tim.2011.04.005 · Cited by 1,286
Wilson and Gisvold's Textbook of Organic Medicinal and Pharmaceutical Chemistry
Beale, J. M., & Block, J. H. (2011) · Andalas University Repository (Andalas University) · Cited by 914
Boucher, H. W., Talbot, G. H., Benjamin, D. K., Bradley, J., Guidos, R. J., Jones, R. N., Murray, B. E., Bonomo, R. A., Gilbert, D., & for the Infectious Diseases Society of America (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit152 · Cited by 700
Penicillin-binding proteins and β-lactam resistance
Zapun, A., Contreras-Martel, C., & Vernet, T. (2008) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2007.00095.x · Cited by 687
Pseudomonas aeruginosa: resistance and therapeutic options at the turn of the new millennium
Mesaros, N., Nordmann, P., Plésiat, P., Roussel-Delvallez, M., Van Eldere, J., Glupczynski, Y., Van Laethem, Y., Jacobs, F., Lebecque, P., Malfroot, A., et al. (2007) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2007.01681.x · Cited by 585
The 10 × ‘20 Initiative: Pursuing a Global Commitment to Develop 10 New Antibacterial Drugs by 2020
(2010) · Clinical Infectious Diseases · doi:10.1086/652237 · Cited by 484
Ceftazidime-Avibactam: a Novel Cephalosporin/β-lactamase Inhibitor Combination
Zhanel, G. G., Lawson, C. D., Adam, H., Schweizer, F., Zelenitsky, S., Lagacé-Wiens, P. R. S., Denisuik, A., Rubinstein, E., Gin, A. S., Hoban, D. J., et al. (2013) · Drugs · doi:10.1007/s40265-013-0013-7 · Cited by 433
Self-citationProgress and Challenges in Implementing the Research on ESKAPE Pathogens
Rice, L. B. (2010) · Infection Control & Hospital Epidemiology · doi:10.1086/655995 · Cited by 370
Ready for a world without antibiotics? The Pensières Antibiotic Resistance Call to Action
Carlet, J., Jarlier, V., Harbarth, S., Voss, A., Goossens, H., Pittet, D., & Forum, T. P. O. T. 3. W. H.-A. I. (2012) · Antimicrobial Resistance and Infection Control · doi:10.1186/2047-2994-1-11 · Cited by 350
β-Lactam Resistance Response Triggered by Inactivation of a Nonessential Penicillin-Binding Protein
Moya, B., Dötsch, A., Juan, C., Blázquez, J., Zamorano, L., Haussler, S., & Oliver, A. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000353 · Cited by 287
Kinetic interactions of tazobactam with beta-lactamases from all major structural classes
Bush, K., Macalintal, C., Rasmussen, B. A., Lee, V. J., & Yang, Y. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.4.851 · Cited by 274
Farrell, D. J., Flamm, R. K., Sader, H. S., & Jones, R. N. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01802-13 · Cited by 203
Zhanel, G. G., Sniezek, G., Schweizer, F., Zelenitsky, S. A., Lagacé-Wiens, P. R. S., Rubinstein, E., Gin, A. S., Hoban, D. J., & Karlowsky, J. A. (2009) · Drugs · doi:10.2165/00003495-200969070-00003 · Cited by 168
Self-citationIn Vitro and In Vivo Activities of a New Cephalosporin, FR264205, against Pseudomonas aeruginosa
Takeda, S., Nakai, T., Wakai, Y., Ikeda, F., & Hatano, K. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00860-06 · Cited by 140
Craig, W. A., & Andes, D. R. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01590-12 · Cited by 138
Sader, H. S., Rhomberg, P. R., Farrell, D. J., & Jones, R. N. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01737-10 · Cited by 123
Chandorkar, G., Huntington, J. A., Gotfried, M. H., Rodvold, K. A., & Umeh, O. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks246 · Cited by 118
Class A β-lactamases—enzyme-inhibitor interactions and resistance
Yang, Y., Rasmussen, B. A., & Shlaes, D. M. (1999) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(99)00027-3 · Cited by 109
VanScoy, B. D., Mendes, R. E., Nicasio, A. M., Castanheira, M., Bulik, C. C., Okusanya, Ó. O., Bhavnani, S. M., Forrest, A., Jones, R. N., Friedrich, L. V., et al. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02513-12 · Cited by 107
Pharmacokinetics and tissue penetration of tazobactam administered alone and with piperacillin
Wise, R. A., Logan, M., Cooper, M., & Andrews, J. M. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.6.1081 · Cited by 70
Luján, A. M., Macia, M. D., Yang, L., Molin, S., Oliver, A., & Smania, A. M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027842 · Cited by 65
Ge, Y., Whitehouse, M. J., Friedland, I. R., & Talbot, G. H. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01753-09 · Cited by 54
Murano, K., Yamanaka, T., Toda, A., Ohki, H., Okuda, S., Kawabata, K., Hatano, K., Takeda, S., Akamatsu, H., Itoh, K., et al. (2007) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2007.11.074 · Cited by 46
Cited by
β-Lactams and β-Lactamase Inhibitors: An Overview
Bush, K., & Bradford, P. A. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a025247 · Cited by 1,412
ESKAPE pathogens: antimicrobial resistance, epidemiology, clinical impact and therapeutics
Miller, W. R., & Arias, C. A. (2024) · Nature Reviews Microbiology · doi:10.1038/s41579-024-01054-w · Cited by 862
Alternatives to antibiotics—a pipeline portfolio review
Czaplewski, L., Bax, R., Clokie, M., Dawson, M., Fairhead, H., Fischetti, V. A., Foster, S., Gilmore, B. F., Hancock, R. E. W., Harper, D., et al. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)00466-1 · Cited by 848
How to manage Pseudomonas aeruginosa infections
Bassetti, M., Vena, A., Croxatto, A., Righi, E., & Guery, B. (2018) · Drugs in Context · doi:10.7573/dic.212527 · Cited by 746
Natural product and natural product derived drugs in clinical trials
Butler, M. S., Robertson, A. A. B., & Cooper, M. A. (2014) · Nat. Prod. Rep. · doi:10.1039/c4np00064a · Cited by 602
Metadata
- Authors
- Zhanel, G. G., Chung, P., Adam, H., Zelenitsky, S., Denisuik, A., Schweizer, F., Lagacé-Wiens, P. R. S., Rubinstein, E., Gin, A. S., Walkty, A., Hoban, D. J., Lynch, J. P., & Karlowsky, J. A.
- Venue
- Drugs
- Published
- 2013-12-19
- Volume
- 74
- Issue
- 1
- Pages
- 31-51
- ISSN
- 0012-6667 (ISSN-L)
- 1179-1950
- OpenAlex
- W1989886020
- Cited by
- 340
- References
- 26
- FWCI
- 9.27
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.